| Frequency of TERT promoter mutations in human cancers J Vinagre, A Almeida, H Pópulo, R Batista, J Lyra, V Pinto, R Coelho, ... Nature communications 4 (1), 2185, 2013 | 1042 | 2013 |
| TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas M Melo, AG da Rocha, J Vinagre, R Batista, J Peixoto, C Tavares, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E754-E765, 2014 | 626 | 2014 |
| Telomerase promoter mutations in cancer: an emerging molecular biomarker? J Vinagre, V Pinto, R Celestino, M Reis, H Pópulo, P Boaventura, M Melo, ... Virchows Archiv 465, 119-133, 2014 | 159 | 2014 |
| TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation H Pópulo, P Boaventura, J Vinagre, R Batista, A Mendes, R Caldas, ... Journal of Investigative Dermatology 134 (8), 2251-2257, 2014 | 152 | 2014 |
| Telomere maintenance mechanisms in cancer T Bordeira Gaspar, A Sá, JM Lopes, M Sobrinho-Simões, P Soares, ... Genes 9 (5), 241, 2018 | 145 | 2018 |
| TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease M Melo, A Gaspar da Rocha, R Batista, J Vinagre, MJ Martins, G Costa, ... The Journal of Clinical Endocrinology & Metabolism 102 (6), 1898-1907, 2017 | 145 | 2017 |
| Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review R Batista, N Vinagre, S Meireles, J Vinagre, H Prazeres, R Leão, ... Diagnostics 10 (1), 39, 2020 | 128 | 2020 |
| Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas P Soares, J Lima, A Preto, P Castro, J Vinagre, R Celestino, J P Couto, ... Current genomics 12 (8), 609-617, 2011 | 127 | 2011 |
| TERT biology and function in cancer: beyond immortalisation A Pestana, J Vinagre, M Sobrinho-Simões, P Soares Journal of molecular endocrinology 58 (2), R129-R146, 2017 | 117 | 2017 |
| The role of ATRX in the alternative lengthening of telomeres (ALT) phenotype JP Amorim, G Santos, J Vinagre, P Soares Genes 7 (9), 66, 2016 | 114 | 2016 |
| Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer R Leão, D Lee, A Figueiredo, T Hermanns, P Wild, M Komosa, I Lau, ... International journal of cancer 144 (7), 1676-1684, 2019 | 88 | 2019 |
| The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism R Batista, A Cruvinel‐Carloni, J Vinagre, J Peixoto, TA Catarino, ... International journal of cancer 139 (2), 414-423, 2016 | 77 | 2016 |
| Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study R Batista, J Vinagre, H Prazeres, C Sampaio, P Peralta, P Conceição, ... Frontiers in genetics 10, 1237, 2019 | 66 | 2019 |
| Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas H Pópulo, J Vinagre, JM Lopes, P Soares British Journal of Ophthalmology 95 (5), 715-719, 2011 | 58 | 2011 |
| Molecular aspects of thyroid calcification LB Ferreira, E Gimba, J Vinagre, M Sobrinho-Simoes, P Soares International Journal of Molecular Sciences 21 (20), 7718, 2020 | 53 | 2020 |
| Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis M Melo, AG da Rocha, J Vinagre, M Sobrinho-Simões, P Soares J Clin Oncol 33 (6), 667-668, 2015 | 50 | 2015 |
| TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma MA Campos, S Macedo, M Fernandes, A Pestana, J Pardal, R Batista, ... Journal of the American Academy of Dermatology 80 (3), 660-669. e6, 2019 | 46 | 2019 |
| Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients CA Sieverink, RPM Batista, HJM Prazeres, J Vinagre, C Sampaio, ... Diagnostics 10 (10), 745, 2020 | 45 | 2020 |
| MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism MI Alvelos, J Vinagre, E Fonseca, E Barbosa, J Teixeira-Gomes, ... European journal of endocrinology 168 (2), 119-128, 2013 | 44 | 2013 |
| mTOR activation in medullary thyroid carcinoma with RAS mutation J Lyra, J Vinagre, R Batista, V Pinto, H Prazeres, F Rodrigues, C Eloy, ... European journal of endocrinology 171 (5), 633-640, 2014 | 43 | 2014 |
Paula SoaresUniversity of Porto, Medical Facultyยืนยันอีเมลแล้วที่ ipatimup.pt
